151 related articles for article (PubMed ID: 33388444)
1. Subdermal Contraceptive Implant Insertion Trends and Retention in Adolescents.
Tyson N; Lopez M; Merchant M; Postlethwaite D
J Pediatr Adolesc Gynecol; 2021 Jun; 34(3):348-354. PubMed ID: 33388444
[TBL] [Abstract][Full Text] [Related]
2. Temporal Trends in the Uptake and Continuation of the Etonogestrel Implant in a Large Private Practice Setting.
Howard DL; Ford A; Ceballos S; Volker KW
J Womens Health (Larchmt); 2018 Feb; 27(2):191-195. PubMed ID: 28976797
[TBL] [Abstract][Full Text] [Related]
3. Six- and twelve-month documented removal rates among women electing postpartum inpatient compared to delayed or interval contraceptive implant insertions after Medicaid payment reform.
Crockett AH; Pickell LB; Heberlein EC; Billings DL; Mills B
Contraception; 2017 Jan; 95(1):71-76. PubMed ID: 27400823
[TBL] [Abstract][Full Text] [Related]
4. Attendance of an Initial Follow-up Visit after Long-Acting Reversible Contraception Insertion and Method Continuation Among Adolescents and Young Adults: A Retrospective Study.
Bryson AE; Cabral HJ; Coles MS
J Pediatr Adolesc Gynecol; 2021 Aug; 34(4):525-529. PubMed ID: 33486086
[TBL] [Abstract][Full Text] [Related]
5. Adolescent Long-Acting Reversible Contraceptive Use, Same-Day Insertions, and Pregnancies Following a Quality Initiative.
Bruce KH; Merchant MA; Kaskowitz AP; Mickelsen RS; Lau JS
J Adolesc Health; 2023 Nov; 73(5):946-952. PubMed ID: 37436353
[TBL] [Abstract][Full Text] [Related]
6. Immediate versus delayed insertion of an etonogestrel releasing implant at medical abortion-a randomized controlled equivalence trial.
Hognert H; Kopp Kallner H; Cameron S; Nyrelli C; Jawad I; Heller R; Aronsson A; Lindh I; Benson L; Gemzell-Danielsson K
Hum Reprod; 2016 Nov; 31(11):2484-2490. PubMed ID: 27664217
[TBL] [Abstract][Full Text] [Related]
7. Prolonged use of the etonogestrel implant and levonorgestrel intrauterine device: 2 years beyond Food and Drug Administration-approved duration.
McNicholas C; Swor E; Wan L; Peipert JF
Am J Obstet Gynecol; 2017 Jun; 216(6):586.e1-586.e6. PubMed ID: 28147241
[TBL] [Abstract][Full Text] [Related]
8. Postpartum contraception: initiation and effectiveness in a large universal healthcare system.
Brunson MR; Klein DA; Olsen CH; Weir LF; Roberts TA
Am J Obstet Gynecol; 2017 Jul; 217(1):55.e1-55.e9. PubMed ID: 28257962
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of early discontinuation and associated factors among a retrospective cohort of etonogestrel contraceptive implant users.
Peterson AM; Brown A; Savage A; Dempsey A
Eur J Contracept Reprod Health Care; 2019 Dec; 24(6):475-479. PubMed ID: 31545110
[No Abstract] [Full Text] [Related]
10. Long acting reversible contraception in postpartum adolescents: early initiation of etonogestrel implant is superior to IUDs in the outpatient setting.
Tocce K; Sheeder J; Python J; Teal SB
J Pediatr Adolesc Gynecol; 2012 Feb; 25(1):59-63. PubMed ID: 22051792
[TBL] [Abstract][Full Text] [Related]
11. The effect of immediate postpartum compared to delayed postpartum and interval etonogestrel contraceptive implant insertion on removal rates for bleeding.
Ireland LD; Goyal V; Raker CA; Murray A; Allen RH
Contraception; 2014 Sep; 90(3):253-8. PubMed ID: 24973904
[TBL] [Abstract][Full Text] [Related]
12. Influence of age on tolerability, safety and effectiveness of subdermal contraceptive implants.
López Del Cerro E; Serrano Diana C; Castillo Cañadas AM; González Mirasol E; García Santos F; Gómez García MT; González de Merlo G
J Obstet Gynaecol; 2018 Oct; 38(7):979-984. PubMed ID: 29553853
[TBL] [Abstract][Full Text] [Related]
13. Intra-abortion contraception with etonogestrel subdermal implant.
Barros Pereira I; Carvalho RM; Graça LM
Eur J Obstet Gynecol Reprod Biol; 2015 Feb; 185():33-5. PubMed ID: 25522115
[TBL] [Abstract][Full Text] [Related]
14. Quality of life of women using the etonogestrel long-acting reversible contraceptive implant after abortion for unplanned pregnancy.
Caruso S; Vitale SG; Fava V; Pasqua SD; Rapisarda AMC; Cianci S
Eur J Contracept Reprod Health Care; 2020 Aug; 25(4):251-258. PubMed ID: 32436733
[TBL] [Abstract][Full Text] [Related]
15. Long acting reversible contraception in adolescents with cardiovascular conditions.
Amies Oelschlager AM; Micks EA; Debiec KE; Nizamic T; Mantrala MD; Prager SW
J Pediatr Adolesc Gynecol; 2014 Dec; 27(6):353-5. PubMed ID: 25256877
[TBL] [Abstract][Full Text] [Related]
16. Initiation and continuation of long-acting reversible contraception in the United States military healthcare system.
Chiles DP; Roberts TA; Klein DA
Am J Obstet Gynecol; 2016 Sep; 215(3):328.e1-9. PubMed ID: 27005514
[TBL] [Abstract][Full Text] [Related]
17. Twelve-month discontinuation of etonogestrel implant in an outpatient pediatric setting.
Berlan E; Mizraji K; Bonny AE
Contraception; 2016 Jul; 94(1):81-6. PubMed ID: 26948183
[TBL] [Abstract][Full Text] [Related]
18. Long-acting reversible contraceptive acceptability and unintended pregnancy among women presenting for short-acting methods: a randomized patient preference trial.
Hubacher D; Spector H; Monteith C; Chen PL; Hart C
Am J Obstet Gynecol; 2017 Feb; 216(2):101-109. PubMed ID: 27662799
[TBL] [Abstract][Full Text] [Related]
19. Condom Use With Long-Acting Reversible Contraception vs Non-Long-Acting Reversible Contraception Hormonal Methods Among Postpartum Adolescents.
Kortsmit K; Williams L; Pazol K; Smith RA; Whiteman M; Barfield W; Koumans E; Kourtis A; Harrison L; Bauman B; Warner L
JAMA Pediatr; 2019 Jul; 173(7):663-670. PubMed ID: 31107513
[TBL] [Abstract][Full Text] [Related]
20. Choice of the levonorgestrel intrauterine device, etonogestrel implant or depot medroxyprogesterone acetate for contraception after aspiration abortion.
Steinauer JE; Upadhyay UD; Sokoloff A; Harper CC; Diedrich JT; Drey EA
Contraception; 2015 Dec; 92(6):553-9. PubMed ID: 26093190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
